Michael H. Mulroy, President and CEO at Asterias Biotherapeutics, Inc. (AST), bought 2,255 shares at $2.22 ($5K) on 2018-02-26, disclosed to the SEC on 2018-02-28.
Scheduled purchase ($5k) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| AST | BUY | 2018-08-29 | $5K | — | Filing → |
| AST | BUY | 2018-07-27 | $5K | — | Filing → |
| AST | BUY | 2018-06-27 | $5K | — | Filing → |